跳至主要内容
临床试验/NCT03060369
NCT03060369Unknown不适用

BWH Critical Care Study of CareGuide for Evaluation of Emerging or Established Shock

Brigham and Women's Hospital1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2012年6月最近更新:
适应症

试验速览

阶段
不适用
入组人数
50
试验地点
1
主要终点
Peak systemic lactate

研究概览

简要总结

This pilot study aims to examine the relationship between continuously measured CareGuide™ muscle oxygen saturation (SmO2), tissue pH and data provided from standard monitoring techniques during the care of subjects with suspected established (Cohort A) or emerging (Cohort B) shock in the intensive care unit (ICU).

详细描述

Approximately 50 subjects meeting recruitment criteria will be enrolled with a minimum of 20 subjects meeting entry criteria for established shock (Cohort A).

Noninvasive near-infrared spectroscopy CareGuide™ measurements of SmO2, tissue pH and hematocrit will be collected from enrollment through device removal. These data will be compared to specific hemodynamic and laboratory parameters obtained as a part of routine care during the CareGuide™ monitoring period.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects who are:
  • To be admitted to the intensive care unit
  • At least 18 years of age
  • Men or Women
  • Informed consent from subject or surrogate
  • Clinical diagnosis of established (Cohort A) or emerging (Cohort B) shock, as described above.

排除标准

  • Subjects with:
  • Body mass index >37
  • Trauma (primary diagnosis)
  • Non-global conditions leading to regional increased lactate production (e.g. isolated thrombotic or embolic phenomena, limb, compartment syndrome)
  • Known untreated hypothyroidism
  • Known hypersensitivity to medical adhesives
  • Suspected carbon monoxide poisoning or methemoglobinemia
  • Goals of care restricting vital sign acquisition
  • Family member of investigators or study staff

结局指标

主要结局

Peak systemic lactate

时间窗: Duration of monitoring (< 1 week)

Cohort A

次要结局

  • Peak systemic lactate(Duration of monitoring (< 1 week))
  • Systemic pH(Duration of monitoring (< 1 week))
  • Temporal assessment of SmO2 and lactate(Duration of monitoring (< 1 week))
  • Standard hemodynamic measures stratified by shock type (cardiogenic, hypovolemic, distributive)(Duration of monitoring (< 1 week))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Stephen D. Wiviott

Associate Professor of Medicine

Brigham and Women's Hospital

研究点 (1)

Loading locations...

相似试验